z-logo
open-access-imgOpen Access
Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
Author(s) -
Qian Li,
Mei Liu,
Fei Ma,
Yang Luo,
Ruigang Cai,
Liming Wang,
Ningzhi Xu,
Binghe Xu
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0136826
Subject(s) - epirubicin , paclitaxel , medicine , breast cancer , oncology , chemotherapy , neoadjuvant therapy , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom